Prudential Financial’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.27M | Buy |
1,556,629
+457,784
| +42% | +$2.14M | 0.01% | 748 |
|
|
2025
Q1 | $6.03M | Buy |
1,098,845
+1,061,900
| +2,874% | +$5.83M | 0.01% | 765 |
|
|
2024
Q4 | $125K | Buy |
36,945
+7,000
| +23% | +$23.7K | ﹤0.01% | 2129 |
|
|
2024
Q3 | $85.3K | Buy |
+29,945
| New | +$85.3K | ﹤0.01% | 2593 |
|
|
2024
Q2 | – | Sell |
-28,675
| Closed | -$63.4K | – | 2797 |
|
|
2024
Q1 | $63.4K | Sell |
28,675
-2,800
| -9% | -$6.19K | ﹤0.01% | 2575 |
|
|
2023
Q4 | $74K | Hold |
31,475
| – | – | ﹤0.01% | 2520 |
|
|
2023
Q3 | $58.5K | Sell |
31,475
-127,400
| -80% | -$237K | ﹤0.01% | 2485 |
|
|
2023
Q2 | $416K | Buy |
+158,875
| New | +$416K | ﹤0.01% | 2198 |
|